Search

Your search keyword '"Wang, Hung-Ming"' showing total 1,266 results
Start Over Author "Wang, Hung-Ming"
1,266 results on '"Wang, Hung-Ming"'

56. A combined analysis of maximum standardized uptake value on FDG-PET, genetic markers, and clinicopathological risk factors in the prognostic stratification of patients with resected oral cavity squamous cell carcinoma

Author

Liao, Chun-Ta, Hsieh, Chia-Hsun, Fan, Wen-Lang, Ng, Shu-Hang, Cheng, Nai-Ming, Lee, Li-Yu, Hsueh, Chuen, Lin, Chien-Yu, Fan, Kang-Hsing, Wang, Hung-Ming, Lin, Chih-Hung, Tsao, Chung-Kan, Kang, Chung-Jan, Fang, Tuan-Jen, Huang, Shiang-Fu, Chang, Kai-Ping, Lee, Li-Ang, Fang, Ku-Hao, Wang, Yu-Chien, Yang, Lan-Yan, and Yen, Tzu-Chen

Published
2020
Full Text
View/download PDF

57. Tumor Depth of Invasion (Tumor > 4 cm/Depth > 10 mm and Depth > 20 mm) and Through Cortex/Skin Invasion are Both Valid Criteria for Classifying Tumors as pT4a in AJCC 2018 Oral Cavity Cancer Staging System

Author

Liao, Chun-Ta, Lee, Li-Yu, Hsueh, Chuen, Lin, Chien-Yu, Fan, Kang-Hsing, Wang, Hung-Ming, Hsieh, Chia-Hsun, Ng, Shu-Hang, Lin, Chih-Hung, Tsao, Chung-Kan, Kang, Chung-Jan, Fang, Tuan-Jen, Huang, Shiang-Fu, Chang, Kai-Ping, Lee, Li-Ang, Fang, Ku-Hao, Wang, Yu-Chien, Lin, Wan-Ni, Hsin, Li-Jen, Yang, Lan Yan, and Yen, Tzu-Chen

Published
2019
Full Text
View/download PDF

58. Social and educational inclusion in Taiwan in relation to elementary Schooling with reference to the UK, particularly Scotland

Author

Wang, Hung-Ming

Subjects
371.9, LB1501 Primary Education
Abstract

Inclusive education, a relatively new education system, provides an environment for both non-disabled and disabled children to interact and to understand each other. The purpose of this study was to investigate relevant key stakeholders’ voices and opinions by means of interviews, observations, focus groups and parental surveys. It started from providing a general background of Taiwan’s history and education to the investigating of current implementation of social policies and primary inclusive education in Taiwan. In conducting the study, an investigation into inclusive education in Taiwan was undertaken, specifically the implementation of inclusive education in primary schools in Tainan region. This study obtained a great deal of information from a wide range of stakeholders: perspectives on inclusive policies were obtained by means of interviews. Non-disabled and disabled children’s daily school life and interactions among other children and teachers were recorded via observations and focus groups whilst data gathered through parental questionnaires provided parents’ opinions, reactions and responses. Starting from the pursuit of human rights in Western societies, the focus then shifted to the context of Taiwanese society. More and more attention on the issue of human rights and disadvantaged groups’ rights are paid and in general, the notion of all human beings are equal is rooted and sprouted in Taiwanese culture. The results showed that, in general, professionals believed that inclusive education was basically positive for both non-disabled and disabled children. Inclusive settings provide an environment for both non-disabled and disabled children to share their experiences so that when children grow up, they would have positive attitudes towards each other. However, some professionals were concerned about the consequences of locating disabled pupils, especially pupils with behavioural disorders, in mainstream schools. In most cases, pupils with physical impairments are more easily accepted than those with behavioural disorder ones. It is still not easy to break the barriers, such as people’s inherent notions towards disadvantaged groups, the reality that some behavioural disorder pupils are aggressive and teachers’ time might be spent more on special need pupils, in such a complicated social system. With regard to learning in inclusive settings; both non-disabled and disabled pupils, in general, felt comfortable or did not feel too much difference in the inclusive classroom. The study highlighted that, in most inclusive classrooms, both non-disabled and disabled pupils could be accepted by each other; and in some cases, non-disabled and disabled pupils liked to be located in the inclusive classroom. Parents, however, had more diverse opinions than in any other stakeholders. Inclusive education, though less than half of total respondents had heard before, was deemed basically good to both non-disabled and disabled pupils and in general, it will become future mainstream. Still, some parents, especially those whose children had been located in an inclusive classroom and had bad experiences, were strongly anti-inclusion. Their primary concern was to protect their own children. Quality of education was also their concern because some parents deeply believed that teachers’ time and attention are sometimes drawn to pupils with special educational needs. In conclusion, key stakeholders viewed inclusive education as a means of providing an environment for both non-disabled and disabled pupils to study and to share their experiences. There may however, be a need to re-think the real role of inclusive classroom because many people merely think of locating both non-disabled and disabled pupils in the same environment as inclusion instead of thinking the moral issue or equality for all when they hear about the term inclusion. This study investigated what key stakeholders’ opinions and responses were when discussing about inclusion. This study also concluded by suggesting and offering some of the main issues needing further consideration: issues related to the resources, shifting people’s impression towards disadvantaged groups and the paramount aim of inclusion. All of which are considered to be important for future implementation of inclusive education. The study concludes by a reflection on the findings in a broader context of Chinese thinking and addresses current Taiwanese education system with reference to Taiwanese culture.

Published
2009

59. Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma

Author

Mai, Hai-Qiang, primary, Chen, Qiu-Yan, additional, Chen, Dongping, additional, Hu, Chaosu, additional, Yang, Kunyu, additional, Wen, Jiyu, additional, Li, Jingao, additional, Shi, Yingrui, additional, Jin, Feng, additional, Xu, Ruilian, additional, Pan, Jianji, additional, Qu, Shenhong, additional, Li, Ping, additional, Hu, Chunhong, additional, Liu, Yi-Chun, additional, Jiang, Yi, additional, He, Xia, additional, Wang, Hung-Ming, additional, Lim, Wan-Teck, additional, Liao, Wangjun, additional, He, Xiaohui, additional, Chen, Xiaozhong, additional, Wang, Siyang, additional, Yuan, Xianglin, additional, Li, Qi, additional, Lin, Xiaoyan, additional, Jing, Shanghua, additional, Chen, Yanju, additional, Lu, Yin, additional, Hsieh, Ching-Yun, additional, Yang, Muh-Hwa, additional, Yen, Chia-Jui, additional, Samol, Jens, additional, Luo, Xianming, additional, Wang, Xiaojun, additional, Tang, Xiongwen, additional, Feng, Hui, additional, Yao, Sheng, additional, Keegan, Patricia, additional, and Xu, Rui-Hua, additional

Published
2023
Full Text
View/download PDF

60. A multicenter retrospective analysis of patients with salivary gland carcinoma treated with postoperative radiotherapy alone or chemoradiotherapy

Author

Cheng-En Hsieh, Rodney, primary, Chou, Yung-Chih, additional, Hung, Chia-Yen, additional, Lee, Li-Yu, additional, Prasad Venkatesulu, Bhanu, additional, Huang, Shiang-Fu, additional, Liao, Chun-Ta, additional, Cheng, Nai-Ming, additional, Wang, Hung-Ming, additional, Wu, Chiao-En, additional, Kang, Chung-Jan, additional, Chen, Miao-Fen, additional, Cheng, Yu-Fan, additional, Yeh, Kun-Yun, additional, Wang, Cheng-Hsu, additional, Chou, Wen-Chi, additional, and Lin, Chien-Yu, additional

Published
2023
Full Text
View/download PDF

62. Comparative clinical outcomes of Taiwanese patients with resected buccal and tongue squamous cell carcinomas

Author

Liao, Chun-Ta, Wen, Yu-Wen, Yang, Lan Yan, Lee, Shu Ru, Ng, Shu-Hang, Liu, Tsang-Wu, Tsai, Sen-Tien, Tsai, Ming-Hsui, Lin, Jin-Ching, Chen, Peir-Rong, Lou, Pei-Jen, Wang, Cheng Ping, Chu, Pen-Yuan, Hwang, Tzer-Zen, Leu, Yi-Shing, Tsai, Kuo-Yang, Terng, Shyuang-Der, Chen, Tsung-Ming, Wang, Cheng-Hsu, Chien, Chih-Yen, Chen, Wen-Cheng, Lee, Li-Yu, Lin, Chien-Yu, Wang, Hung-Ming, Hsieh, Chia-Hsun, Tsao, Chung-Kan, Fang, Tuan-Jen, Huang, Shiang-Fu, Kang, Chung-Jan, Chang, Kai-Ping, and Yen, Tzu-Chen

Published
2017
Full Text
View/download PDF

66. Publisher Correction: Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial

Author

Mai, Hai-Qiang, Chen, Qiu-Yan, Chen, Dongping, Hu, Chaosu, Yang, Kunyu, Wen, Jiyu, Li, Jingao, Shi, Ying-Rui, Jin, Feng, Xu, Ruilian, Pan, Jianji, Qu, Shenhong, Li, Ping, Hu, Chunhong, Liu, Yi-Chun, Jiang, Yi, He, Xia, Wang, Hung-Ming, Lim, Wan-Teck, Liao, Wangjun, He, Xiaohui, Chen, Xiaozhong, Liu, Zhigang, Yuan, Xianglin, Li, Qi, Lin, Xiaoyan, Jing, Shanghua, Chen, Yanju, Lu, Yin, Hsieh, Ching-Yun, Yang, Muh-Hwa, Yen, Chia-Jui, Samol, Jens, Feng, Hui, Yao, Sheng, Keegan, Patricia, and Xu, Rui-Hua

Published
2022
Full Text
View/download PDF

67. Clinical outcomes of cetuximab‐based treatment for distant metastatic head and neck squamous cell carcinoma: A real‐world study using Taiwan Head Neck Society registry database.

Author

Lu, Hsueh‐Ju, Hsieh, Meng‐Che, Wang, Hung‐Ming, Hsieh, Jason Chia‐Hsun, Yen, Chia‐Jui, Wu, Shang‐Yin, Huang, Huai‐Cheng, Wang, Hui‐Ching, Chu, Pen‐Yuan, Chen, Tien‐Hua, Chien, Chih‐Yen, Huang, Tai‐Lin, Chang, Yi‐Fang, Hua, Chun‐Hung, Lien, Ming‐Yu, Chen, Jo‐Pai, Lu, Wei‐Chen, Lin, Jin‐Ching, Wang, Chen‐Chi, and Liu, Yi‐Chun

Subjects
SQUAMOUS cell carcinoma, HEAD & neck cancer, DATABASES, BETEL nut, TREATMENT effectiveness, OLDER patients
Abstract

Background: For R/M HNSCC, the differences in prognosis and treatment options between distant metastasis (DM) and locoregional recurrence, especially in the DM group, remain unclear. Methods: From the Taiwan Head Neck Society registry database, patients who were diagnosed with R/M HNSCC and received cetuximab‐based frontline therapy were collected for analysis. Results: Among the enrolled patients, 59.3% (491/827) belonged to the DM group. The DM group had less primary site of oral cavity, less betel nut chewing, higher lactate dehydrogenase (LDH) levels, and higher LDH/albumin ratio compared with the non‐DM group. For the patients with primary site of oral cavity and current smokers, DM coexisted with poorer outcomes. In the DM group, EXTREME‐like regimen was more suitable for older patients, those with elevated LDH, and those with higher LDH/albumin ratio than TPExtreme‐like regimen. Conclusion: DM coexisted with poorer prognosis in certain groups. LDH‐associated biomarkers may aid treatment options for DM patients. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

69. Association between the diagnosis-to-treatment interval and overall survival in Taiwanese patients with oral cavity squamous cell carcinoma

Author

Liao, Chun-Ta, Chen, Hsin-Ni, Wen, Yu-Wen, Lee, Shu Ru, Ng, Shu-Hang, Liu, Tsang-Wu, Tsai, Sen-Tien, Tsai, Ming-Hsui, Lin, Jin-Ching, Lou, Pei-Jen, Wang, Cheng Ping, Chu, Pen-Yuan, Leu, Yi-Shing, Tsai, Kuo-Yang, Terng, Shyuang-Der, Chen, Tsung-Ming, Wang, Cheng-Hsu, Chien, Chih-Yen, Chen, Wen-Cheng, Lee, Li-Yu, Lin, Chien-Yu, Wang, Hung-Ming, Lin, Chih-Hung, Fang, Tuan-Jen, Huang, Shiang-Fu, Kang, Chung-Jan, Chang, Kai-Ping, Yang, Lan Yan, and Yen, Tzu-Chen

Published
2017
Full Text
View/download PDF

71. Second Heart Sound (S2) Decomposition by Hilbert Vibration Decomposition (HVD) for Affective Signal Modeling and Learning

Author

Barma, Shovan, Chen, Bo-Wei, Wang, Hung-Ming, Wang, Hung-Jui, Wang, Jhing-Fa, Hutchison, David, Series editor, Kanade, Takeo, Series editor, Kittler, Josef, Series editor, Kleinberg, Jon M., Series editor, Mattern, Friedemann, Series editor, Mitchell, John C., Series editor, Naor, Moni, Series editor, Pandu Rangan, C., Series editor, Steffen, Bernhard, Series editor, Terzopoulos, Demetri, Series editor, Tygar, Doug, Series editor, Weikum, Gerhard, Series editor, Chiu, Dickson K. W., editor, Wang, Minhong, editor, Popescu, Elvira, editor, Li, Qing, editor, Lau, Rynson, editor, Shih, Timothy K., editor, Yang, Chu-Sing, editor, and Sampson, Demetrios G., editor

Published
2015
Full Text
View/download PDF

74. Supplementary Table 1, Figure Legends 1-3 from Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling

Author

Lu, Ya-Ching, primary, Chen, Yin-Ju, primary, Wang, Hung-Ming, primary, Tsai, Chi-Ying, primary, Chen, Wen-Ho, primary, Huang, Yu-Chen, primary, Fan, Kang-Hsing, primary, Tsai, Chi-Neu, primary, Huang, Shiang-Fu, primary, Kang, Chung-Jan, primary, Chang, Joseph Tung-Chieh, primary, and Cheng, Ann-Joy, primary

Published
2023
Full Text
View/download PDF

76. Supplementary Figure 2C from Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling

Author

Lu, Ya-Ching, primary, Chen, Yin-Ju, primary, Wang, Hung-Ming, primary, Tsai, Chi-Ying, primary, Chen, Wen-Ho, primary, Huang, Yu-Chen, primary, Fan, Kang-Hsing, primary, Tsai, Chi-Neu, primary, Huang, Shiang-Fu, primary, Kang, Chung-Jan, primary, Chang, Joseph Tung-Chieh, primary, and Cheng, Ann-Joy, primary

Published
2023
Full Text
View/download PDF

77. Supplementary Figure 1 from Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling

Author

Lu, Ya-Ching, primary, Chen, Yin-Ju, primary, Wang, Hung-Ming, primary, Tsai, Chi-Ying, primary, Chen, Wen-Ho, primary, Huang, Yu-Chen, primary, Fan, Kang-Hsing, primary, Tsai, Chi-Neu, primary, Huang, Shiang-Fu, primary, Kang, Chung-Jan, primary, Chang, Joseph Tung-Chieh, primary, and Cheng, Ann-Joy, primary

Published
2023
Full Text
View/download PDF

78. Supplementary Figure 3A from Oncogenic Function and Early Detection Potential of miRNA-10b in Oral Cancer as Identified by microRNA Profiling

Author

Lu, Ya-Ching, primary, Chen, Yin-Ju, primary, Wang, Hung-Ming, primary, Tsai, Chi-Ying, primary, Chen, Wen-Ho, primary, Huang, Yu-Chen, primary, Fan, Kang-Hsing, primary, Tsai, Chi-Neu, primary, Huang, Shiang-Fu, primary, Kang, Chung-Jan, primary, Chang, Joseph Tung-Chieh, primary, and Cheng, Ann-Joy, primary

Published
2023
Full Text
View/download PDF

79. Figure S5 from Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging

Author

Cheng, Nai-Ming, primary, Yao, Jiawen, primary, Cai, Jinzheng, primary, Ye, Xianghua, primary, Zhao, Shilin, primary, Zhao, Kui, primary, Zhou, Wenlan, primary, Nogues, Isabella, primary, Huo, Yuankai, primary, Liao, Chun-Ta, primary, Wang, Hung-Ming, primary, Lin, Chien-Yu, primary, Lee, Li-Yu, primary, Xiao, Jing, primary, Lu, Le, primary, Zhang, Ling, primary, and Yen, Tzu-Chen, primary

Published
2023
Full Text
View/download PDF

81. Supplementary Table 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

82. Supplementary Table 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

83. Supplementary Table 5 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

84. Supplementary Figure 1 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

85. Supplementary Figure 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

87. Supplementary Table 4 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

88. Supplementary Tables from Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging

Author

Cheng, Nai-Ming, primary, Yao, Jiawen, primary, Cai, Jinzheng, primary, Ye, Xianghua, primary, Zhao, Shilin, primary, Zhao, Kui, primary, Zhou, Wenlan, primary, Nogues, Isabella, primary, Huo, Yuankai, primary, Liao, Chun-Ta, primary, Wang, Hung-Ming, primary, Lin, Chien-Yu, primary, Lee, Li-Yu, primary, Xiao, Jing, primary, Lu, Le, primary, Zhang, Ling, primary, and Yen, Tzu-Chen, primary

Published
2023
Full Text
View/download PDF

89. Supplementary Figure 3 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

90. Supplementary Table 7 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

91. Supplementary Table 2 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

92. Supplementary Protocol from Deep Learning for Fully Automated Prediction of Overall Survival in Patients with Oropharyngeal Cancer Using FDG-PET Imaging

Author

Cheng, Nai-Ming, primary, Yao, Jiawen, primary, Cai, Jinzheng, primary, Ye, Xianghua, primary, Zhao, Shilin, primary, Zhao, Kui, primary, Zhou, Wenlan, primary, Nogues, Isabella, primary, Huo, Yuankai, primary, Liao, Chun-Ta, primary, Wang, Hung-Ming, primary, Lin, Chien-Yu, primary, Lee, Li-Yu, primary, Xiao, Jing, primary, Lu, Le, primary, Zhang, Ling, primary, and Yen, Tzu-Chen, primary

Published
2023
Full Text
View/download PDF

93. Supplementary Table 6 from Phase II, Randomized Study of Spartalizumab (PDR001), an Anti–PD-1 Antibody, versus Chemotherapy in Patients with Recurrent/Metastatic Nasopharyngeal Cancer

Author

Even, Caroline, primary, Wang, Hung-Ming, primary, Li, Shau-Hsuan, primary, Ngan, Roger K-C, primary, Dechaphunkul, Arunee, primary, Zhang, Li, primary, Yen, Chia-Jui, primary, Chan, Po Chung, primary, Chakrabandhu, Somvilai, primary, Ma, Brigette B.Y., primary, Tanasanvimon, Suebpong, primary, Lee, Victor H.F., primary, Lou, Pei-Jen, primary, Li, Zujun, primary, Spira, Alexander I., primary, Sukari, Ammar, primary, Guigay, Joël, primary, McCune, Steven, primary, Gonzalez-Maffe, Juan, primary, Szpakowski, Sebastian, primary, Yao, Yao, primary, Liang, Hongzi, primary, Mataraza, Jennifer, primary, Séchaud, Romain, primary, Manenti, Luigi, primary, and Lim, Darren W-T., primary

Published
2023
Full Text
View/download PDF

97. Clinical Outcomes of Taiwanese Patients with cT4 Oral Cavity Squamous Cell Carcinoma: Toward the Identification of the Optimal Initial Treatment Approach for cT4b Patients

Author

Liao, Chun-Ta, Wen, Yu-Wen, Lee, Shu Ru, Liu, Tsang-Wu, Tsai, Sen-Tien, Tsai, Ming-Hsui, Lin, Jin-Ching, Lou, Pei-Jen, Chu, Pen-Yuan, Leu, Yi-Shing, Tsai, Kuo-Yang, Terng, Shyuang-Der, Chen, Tsung-Ming, Wang, Cheng-Hsu, Chien, Chih-Yen, Chen, Wen-Cheng, Lee, Li-Yu, Lin, Chien-Yu, Wang, Hung-Ming, Ng, Shu-Hang, Lin, Chih-Hung, Fang, Tuan-Jen, Huang, Shiang-Fu, Kang, Chung-Jan, Chang, Kai-Ping, Yang, Lan Yan, Yen, Tzu-Chen, and for the Taiwan Oral Cancer Advisory Group

Published
2017
Full Text
View/download PDF

99. International recommendations for plasma Epstein-Barr virus DNA measurement in nasopharyngeal carcinoma in resource-constrained settings: lessons from the COVID-19 pandemic

Author

Lee, Victor Ho-Fun, primary, Adham, Marlinda, additional, Ben Kridis, Wala, additional, Bossi, Paolo, additional, Chen, Ming-Yuan, additional, Chitapanarux, Imjai, additional, Gregoire, Vincent, additional, Hao, Sheng Po, additional, Ho, Cheryl, additional, Ho, Gwo Fuang, additional, Kannarunimit, Danita, additional, Kwong, Dora Lai-Wan, additional, Lam, Ka-On, additional, Lam, Wai Kei Jacky, additional, Le, Quynh-Thu, additional, Lee, Anne Wing-Mui, additional, Lee, Nancy Y, additional, Leung, To-Wai, additional, Licitra, Lisa, additional, Lim, Darren Wan-Teck, additional, Lin, Jin-Ching, additional, Loh, Kwok Seng, additional, Lou, Pei-Jen, additional, Machiels, Jean-Pascal, additional, Mai, Hai-Qiang, additional, Mesía, Ricard, additional, Ng, Wai-Tong, additional, Ngan, Roger Kai-Cheong, additional, Tay, Joshua K, additional, Tsang, Raymond King-Yin, additional, Tong, Chi-Chung, additional, Wang, Hung-Ming, additional, and Wee, Joseph T, additional

Published
2022
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results